STAA - STAAR Surgical Company
| Previous Close | 37.69 |
| Open | 37.63 |
| Bid | 37.36 x 900 |
| Ask | 53.99 x 800 |
| Day's Range | 37.26 - 37.76 |
| 52 Week Range | 21.70 - 41.65 |
| Volume | 165,128 |
| Avg. Volume | 354,084 |
| Market Cap | 1.7B |
| Beta (5Y Monthly) | 2.36 |
| PE Ratio (TTM) | 207.94 |
| EPS (TTM) | 0.18 |
| Earnings Date | Feb 19, 2020 - Feb 24, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 49.00 |
- Insider Monkey
Here is What Hedge Funds Think About STAAR Surgical Company (STAA)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Our research shows that most of the stocks that smart money likes historically generate strong […]
- Business Wire
STAAR Surgical Announces FDA IDE Clinical Study Approval
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing that the FDA in a letter dated December 6, 2019, stated that it has determined that STAAR has provided sufficient data to support initiation of a human clinical study in the United States of the EVO/EVO+ VISIAN® Implantable Collamer® Lens for Myopia, and EVO/EVO+ VISIAN® Toric Implantable Collamer® Lens for Myopia with Astigmatism.
- Thomson Reuters StreetEvents
Edited Transcript of STAA earnings conference call or presentation 30-Oct-19 8:30pm GMT
Q3 2019 STAAR Surgical Co Earnings Call
- Simply Wall St.
STAAR Surgical (NASDAQ:STAA) Seems To Use Debt Rather Sparingly
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
- Business Wire
STAAR Surgical to Host Investor and Analyst Day on November 8, 2019
STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced today that the Company will host an Investor and Analyst Day on Friday, November 8, 2019 in New York City at 8:30 a.m. EST. A webcast with accompanying slides of a presentation by Caren Mason, President and CEO of STAAR Surgical, and a presentation by Dr. Mark Packer will be available on the “Investors” page of the Company's website at https://www.staar.com/.
- Zacks
Staar Surgical (STAA) Beats Q3 Earnings and Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of 33.33% and 4.15%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
STAAR Surgical Reports Third Quarter Results
STAAR Surgical Company , a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 27, 2019.
- Simply Wall St.
Based On Its ROE, Is STAAR Surgical Company (NASDAQ:STAA) A High Quality Stock?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- Insider Monkey
Were Hedge Funds Right About Selling STAAR Surgical Company (STAA)?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
- Zacks
Staar Surgical (STAA) Earnings Expected to Grow: Should You Buy?
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Business Wire
STAAR Surgical Celebrates Visual Freedom with Jorgensen Family
STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Dr. Jorn S. Jorgensen successfully implanted the Company’s EVO Visian ICL in his son, Jannik Jorgensen, during a live-streamed event which also celebrated the opening of EuroEyes’ newest clinic. Dr. Jorgensen is the founder, chairman, executive director and CEO of the EuroEyes clinic group, with clinics across Germany, Denmark and China.
- Business Wire
STAAR Surgical to Report Third Quarter Results on October 30, 2019
STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 27, 2019 on Wednesday, October 30, 2019 after the market close. STAAR will host a conference call and webcast on Wednesday, October 30 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress. To access the conference call (Conference ID 7170127), please dial 855-765-5684 for domestic participants and 262-912-6252 for international participants.
- Simply Wall St.
STAAR Surgical Company (NASDAQ:STAA) Has Attractive Fundamentals
Attractive stocks have exceptional fundamentals. In the case of STAAR Surgical Company (NASDAQ:STAA), there's is a...
- Simply Wall St.
Should STAAR Surgical Company’s (NASDAQ:STAA) Weak Investment Returns Worry You?
Today we'll look at STAAR Surgical Company (NASDAQ:STAA) and reflect on its potential as an investment. To be precise...
- Thomson Reuters StreetEvents
Edited Transcript of STAA earnings conference call or presentation 31-Jul-19 8:30pm GMT
Q2 2019 STAAR Surgical Co Earnings Call
- Simply Wall St.
Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- Motley Fool
Why STAAR Surgical Stock Is Skyrocketing Today
Great second-quarter earnings results sent the implantable contact lens maker's stock into orbit.
Motley FoolStaar Surgical Co (STAA) Q2 2019 Earnings Call Transcript
STAA earnings call for the period ending June 30, 2019.
- Zacks
Staar Surgical (STAA) Beats Q2 Earnings Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of 40.00% and -1.09%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Is STAAR Surgical Company's (NASDAQ:STAA) CEO Salary Justified?
In 2015 Caren Mason was appointed CEO of STAAR Surgical Company (NASDAQ:STAA). First, this article will compare CEO...
